We studied tumors from postmenopausal women with node-positive or >2 cm ER+ and/or PR + , HER2- breast cancer enrolled on the FELINE clinical trial (clinicaltrials.gov # NCT02712723). The gene discussed is ESR1; the disease is breast cancer.